# TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B

> **NCT04843852** · PHASE1 · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 10 (estimated)

## Conditions studied

- Hepatitis B
- Chronic Hepatitis B

## Interventions

- **DRUG:** Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]

## Key facts

- **NCT ID:** NCT04843852
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-16
- **Primary completion:** 2026-10-31
- **Final completion:** 2027-04-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04843852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04843852, "TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04843852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*